CL-108

Discussion in 'Daiichi-Sankyo' started by anonymous, Jul 7, 2016 at 11:19 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Look up Edarbi, which had superiority data against Benicar, Diovan, and Cozaar.
     

  2. anonymous

    anonymous Guest

    Go do your homework monkey, also try to grasp a simple concept, you've accomplished nothing, you win at nothing and you are a sales rep at DSI. You are at the pinnacle of your professional life. Congrats lard ass
     
  3. anonymous

    anonymous Guest

    Love it when Rob L goes crazy on CP.
     
  4. anonymous

    anonymous Guest

    Rob-you are an idiot-and really short-This industry has been all about coverage for the past 15 years. No one will cover mira when lyrica generic is available. Maybe we can sell the value proposition of Miregab-oh wait that is what we did with Savaysa and reason we got no coverage. Got to love great leadership!!!!!!!!!!!!!